Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity

NCT06171152 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT06171152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06171152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Suspended
Start date
January 26, 2024
Completion date
October 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia in remission, long covid, long covid19, multiple sclerosis, obese, obesity, obesity, morbid